替比夫定阻断血清HBV高载量孕妇母婴传播的疗效和安全性观察*

doi:10.3969/j.issn.1672-5069.2015.04.021

Abstract

Zhang Xianhua. Efficacy and safety of telbivudine in preventing mother-to-infant transmission of hepatitis B viral infection in pregnant women with high serum hepatitis B viral load[J]. JOURNAL OF PRACTICAL HEPATOLOGY, 2015, 18(4): 411-412.

References

[1] 郭红娟，张芸. 替比夫定阻断HBV高载量孕妇母婴传播的作用观察. 长治医学院学报，2011，25（5）:368-370.
[2] Sinha S，Kumar M. Pregnancy and chronic hepatitis B virus infection. Hepatol Res，2010，40（1）:31-48.
[3] 韩国荣，江红秀，王根菊，等. 替比夫定对乙型肝炎病毒高载量孕妇母婴传播的阻断效果及其安全性.中华肝脏病杂志，2012，20（3）:201-205.
[4] Tran TT. Management of hepatitis B in pregnancy:weighing the options. Cleve Clin J Med，2009，76（Suppl3）:s25-s29.
[5] 中华医学会肝病学分会和感染病学分会.慢性乙型肝炎防治指南（2010年版）. 实用肝脏病杂志，2011，14（2）：81-89.
[6] 张彦芳，胡玉红. 替比夫定阻断乙型肝炎病毒母婴传播的疗效和安全性. 药物不良反应杂志，2010，12（3）:157-159.
[7] Bai GQ，Li SH，Yue YF，et al. The study on role of peripheral blood mononuclear cell in HBV intrauterine infection. Arch Gynecol Obstet，2011，283（2）:317-321.
[8] 赵世印，李儒贵，谭华炳. 慢性乙型肝炎妊娠全程替比夫定抗病毒治疗母婴随访1年报道. 湖北医药学院学报，2013，32（4）:343-344.
[9] 陈君，孙晓风，邓泽润，等. 妊娠晚期应用替比夫定阻断乙型肝炎病毒宫内感染疗效和安全性的系统评价.实用肝脏病杂志，2014，17（3）:249-254.
[10] 彭保安，赵轶，杨小福，等. 替比夫定阻断乙型肝炎病毒母婴传播的疗效和安全性研究.中国药学杂志，2012，47（11）:855-857.
[11] 姚展成，陈明纯，廖文燕，等. 替比夫定阻断乙型肝炎病毒宫内感染效果和安全性研究. 实用肝脏病杂志，2011，14（4）:259-261.
[12] Bridges EG，Selden JR，Luo S. Nonclinical safety profile of telbivudine，a novel potent antiviral agent for treatment of hepatitis B. Antimicrob Agents Chemother，2008，52（7）:2521-2528.
[13] 曾艳梅，张思泉，娄国强，等. 替比夫定阻断乙型肝炎病毒宫内感染的临床研究. 中国临床药理学与治疗学，2010，15（4）:443-445.
[14] Pan CQ，Han GR，Jiang HX，et al. Telbivudine prevents vertical transmission from HBeAg-positive women with chronic hepatitis B. Clin Gastroenterol Hepatol，2012，10（5）:520-526.

[1]	chronic hepatitis B Zhu Lingyun, Zhang Maohai Cui Shasha, et al.. Serum IL-12 and IL-18 levels as well as peripheral blood mononuclear cell FOXp3 in patients with [J]. Journal of Practical Hepatology, 2019, 22(6): 816-819.
[2]	Shi Yingying, Wang Yuanxi.. Impact of combination telbivudine and adefovir dipivoxil on renal functions in the treatment of patients with chronic hepatitis B [J]. Journal of Practical Hepatology, 2019, 22(6): 820-823.
[3]	Min Feng, Huang Wenqi, Wu Weibing, et al.. Implications of serum adipocytokine levels in patients with chronic hepatitis B [J]. Journal of Practical Hepatology, 2019, 22(6): 824-827.
[4]	patients with chronic hepatitis B Zhang Yingming, Shen Shuang, Tian Fei, et al.. Prediction of response to peginterferon alfa-2a by blood IFNL4 and IL-28B gene polymorphisms in [J]. Journal of Practical Hepatology, 2019, 22(6): 828-831.
[5]	chronic hepatitis B virus carriers Wu Haiyi, Chen Jianxin.. Diagnostic efficacy of four non-invasive diagnostic models in evaluating significant liver fibrosis in [J]. Journal of Practical Hepatology, 2019, 22(6): 832-835.
[6]	Ma Liying, Shen Lijuan.. Efficacy and safety of tenofovir in the treatment of pregnant women with high HBV DNA loads [J]. Journal of Practical Hepatology, 2019, 22(6): 836-839.
[7]	Tang Renyi, Hu Qunfeng, Peng Liqing.. Changes of serum lipids, liver function tests and estrogen levels in patients with intrahepatic cholestasis of pregnancy and its clinical significance [J]. Journal of Practical Hepatology, 2019, 22(6): 860-863.
[8]	Duan Chuyao, Chen Qingshan, Wang Liming, et al.. Clinical efficacy of ursodeoxycholic acid in treatment of patients with intrahepatic cholestasis of pregnancy [J]. Journal of Practical Hepatology, 2019, 22(6): 864-867.
[9]	Li Chuanjie, Xu Jing, Wang Liangliang, et al.. Changes of serum HBsAg levels in patients with chronic hepatitis B receiving entecavir treatment [J]. Journal of Practical Hepatology, 2019, 22(6): 928-929.
[10]	Du Keye, Yang Dongliang, Liu Jia. Regulatory T cells in hepatitis B [J]. Journal of Practical Hepatology, 2019, 22(5): 613-616.
[11]	Liao Guichan, Peng Jie, Zhang Xiaoyong. Roles of hepatocytes in intrinsic innate immunity in control of hepatits B virus infection [J]. Journal of Practical Hepatology, 2019, 22(5): 617-619.
[12]	Zhao Xieshan, Wu Chunrong, Wang Chunfeng, et al. Preliminary study on the efficacy of combination of tenofovir and Anluo Huaxian pill in the treatment of patients with HBeAg-negative chronic hepatitis B [J]. Journal of Practical Hepatology, 2019, 22(5): 644-647.
[13]	Tu Jiexia, Wang An’na, Liao Ruoxi. Comparative study of interferon alpha -2b and peginterferon alpha -2a in the treatment of patients with chronic hepatitis B [J]. Journal of Practical Hepatology, 2019, 22(5): 648-651.
[14]	Gao Wei, Hou Yong. Diagnostic efficacy of hepatic fibrosis by liver stiffness measurement in patients with chronic hepatitis B [J]. Journal of Practical Hepatology, 2019, 22(5): 652-655.
[15]	Hu Qunfeng, Yang Li. Pregnancy outcomes in 112 patients with liver injuries during gestation periods [J]. Journal of Practical Hepatology, 2019, 22(5): 664-667.

Efficacy and safety of telbivudine in preventing mother-to-infant transmission of hepatitis B viral infection in pregnant women with high serum hepatitis B viral load

PDF (PC)

Knowledge

Abstract

Cite this article

share this article

References

Related Articles 15

Recommended Articles

Metrics

Comments